Shares in Caterpillar (NYSE: CAT) were down by 3% in today's trading at 3:20 p.m. ET. The decline comes on a bad day for the markets overall and, more importantly, for the commodities that drive orders...
Canada's main stock index opened lower on Monday, dragged by losses in energy shares, while U.S. President ...
1 Cash-Producing Stock with Exciting Potential and 2 to Turn Down
Caterpillar Inc. CAT and Deere & Company DE are two of the world’s leading heavy equipment manufacturers. Caterpillar, widely recognized by its signature yellow machines, manufactures construction and...
The US dollar has been falling since the beginning of 2025 down over 6% by April, which makes American products cheaper for overseas buyers helping boost demand
/CNW/ - Toromont Industries Ltd. (TSX: TIH) will release its first quarter 2025 results after markets close on April 30, 2025. Analysts, members of the media...
Joseph Creed’s promotion comes less than a year after he was named COO as part of the company’s broader succession plan.
/CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for...
Construction Machinery Q4 Earnings: Astec (NASDAQ:ASTE) is the Best in the Biz
Rep. Marjorie Taylor Greene is under scrutiny for timely stock purchases in tech and logistics companies that stand to benefit from President Donald Trump’s temporary tariff rollbacks.
Why Myriad Genetics (MYGN) Shares Are Plunging Today
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings
Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings
Why Myriad Genetics (MYGN) Shares Are Plunging Today
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings
Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings
Why Myriad Genetics (MYGN) Shares Are Plunging Today
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings
Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings